Literature DB >> 18690711

Investigations of the MceIJ-catalyzed posttranslational modification of the microcin E492 C-terminus: linkage of ribosomal and nonribosomal peptides to form "trojan horse" antibiotics.

Elizabeth M Nolan1, Christopher T Walsh.   

Abstract

MceIJ is a two protein complex responsible for attachment of a C-glycosylated and linearized derivative of enterobactin, an iron scavenger (siderophore) and product of nonribosomal peptide synthetase machinery, to the C-terminal serine residue of microcin E492 (MccE492), an 84 aa ribosomal antibiotic peptide produced by Klebsiella pneumoniae RYC492. The MceIJ-catalyzed formation of the glycosyl ester linkage between MccE492 and the siderophore requires ATP and Mg(II) as cofactors. This work addresses the ATP utilization, mechanism of C-terminal carboxylate activation, and substrate scope of MceIJ. Formation of the ribosomal peptide-nonribosomal peptide linkage between the MccE492 C-terminal decapeptide and monoglycosylated enterobactin (MGE) requires cleavage of the alpha,beta bond of ATP and formation of a putative peptidyl-CO-AMP intermediate. Attack of the peptidyl-CO-AMP carbonyl by the deprotonated C4' hydroxyl of the glucose moiety forms a glycosyl ester linkage with release of AMP. Site-directed mutagenesis of the three cysteines and five histidines in MceI to alanines reveals that these residues are not required structurally or catalytically. MceIJ recognizes all glycosylated enterobactin derivatives formed by the MccE492 gene cluster members MceC ( C-glycosyltransferase) and MceD (esterase) in vitro and a MGE derivative lacking the C6' hydroxyl moiety. The protein complex also accepts and modifies the C-terminal decapeptide substrate fragments of the structurally related microcins H47, I47, and M. MccE492 C-terminal decapeptides bearing fluorescein and biotin moieties on the N-terminus are also substrates for MceIJ, which provides a route for the chemoenzymatic synthesis of enterobactin conjugates with peptide linkages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690711     DOI: 10.1021/bi800826j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

Review 1.  How nature morphs peptide scaffolds into antibiotics.

Authors:  Elizabeth M Nolan; Christopher T Walsh
Journal:  Chembiochem       Date:  2009-01-05       Impact factor: 3.164

Review 2.  G.I. pros: Antimicrobial defense in the gastrointestinal tract.

Authors:  Lawton K Chung; Manuela Raffatellu
Journal:  Semin Cell Dev Biol       Date:  2018-02-12       Impact factor: 7.727

Review 3.  Exploiting bacterial iron acquisition: siderophore conjugates.

Authors:  Cheng Ji; Raúl E Juárez-Hernández; Marvin J Miller
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

Review 4.  Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome: Where There Is a Will, There Is a Way.

Authors:  Justyna Fert-Bober; Christopher I Murray; Sarah J Parker; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

Review 5.  No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens.

Authors:  Martina Sassone-Corsi; Manuela Raffatellu
Journal:  J Immunol       Date:  2015-05-01       Impact factor: 5.422

6.  The phosphoenolpyruvate:sugar phosphotransferase system is involved in sensitivity to the glucosylated bacteriocin sublancin.

Authors:  C V Garcia De Gonzalo; E L Denham; R A T Mars; J Stülke; W A van der Donk; J M van Dijl
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

7.  Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47.

Authors:  Gaëlle Vassiliadis; Delphine Destoumieux-Garzón; Carine Lombard; Sylvie Rebuffat; Jean Peduzzi
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

Review 8.  The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.

Authors:  Sohn Kim; April Covington; Eric G Pamer
Journal:  Immunol Rev       Date:  2017-09       Impact factor: 12.988

Review 9.  Antibiotics from microbes: converging to kill.

Authors:  Michael A Fischbach
Journal:  Curr Opin Microbiol       Date:  2009-08-18       Impact factor: 7.934

Review 10.  Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates.

Authors:  Timothy A Wencewicz; Ute Möllmann; Timothy E Long; Marvin J Miller
Journal:  Biometals       Date:  2009-02-17       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.